Effect of Omega-3 fatty acids, fibrates and PCSK9 inhibitors on atherosclerotic plaque burden, composition and stability: Insights from imaging
Authors:
- 7 June 2026
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 285, 109058
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Achieved levels of apolipoprotein B and plaque composition after acute coronary syndromes: Insights from HUYGENSAtherosclerosis, 2025
- Intensive lipid lowering agents and coronary atherosclerosis: Insights from intravascular imagingAmerican Journal of Preventive Cardiology, 2022
- Cardiac CT angiography in current practice: An American society for preventive cardiology clinical practice statement✰American Journal of Preventive Cardiology, 2022
- Association of Statin Treatment With Progression of Coronary Atherosclerotic Plaque CompositionJAMA Cardiology, 2021
- Regression in carotid plaque lipid content and neovasculature with PCSK9 inhibition: A time course studyAtherosclerosis, 2021
- Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular RiskJAMA, 2020
- Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated PatientsJAMA, 2016
- Stabilizing effect of combined eicosapentaenoic acid and statin therapy on coronary thin-cap fibroatheromaAtherosclerosis, 2014
- Statins, High-Density Lipoprotein Cholesterol, and Regression of Coronary AtherosclerosisJAMA, 2007
- Fenofibrate induces plaque regression in hypercholesterolemic atherosclerotic rabbits: In vivo demonstration by high-resolution MRIAtherosclerosis, 2007